TITLE

Infection control Update

PUB. DATE
February 2005
SOURCE
Healthcare Purchasing News;Feb2005, Vol. 29 Issue 2, p26
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Presents news briefs on the health care industry as of February 2005. Information on the safety-engineered BD Integra 1ml Retracting Tuberculin and Insulin Syringe released by Becton, Dickenson, and Company; Clearance received by ID Biomedical from the U.S. Food and Drug Administration to run a clinical trial for its injectable flu vaccine; Hospital closure of Lions Gate Hospital in North Vancouver, B.C. due to an outbreak of superbug VRE antibiotic-resistant bacteria.
ACCESSION #
15909321

 

Related Articles

  • REPORTER'S NOTEBOOK.  // Drug Store News;9/27/2004, Vol. 26 Issue 12, p33 

    Reports developments in the U.S. as of September 2004. Delay of the production of Fluvirin influenza virus vaccine; Approval of Cymbalta for treating diabetic peripheral neuropathic pain by the Food and Drug Administration; Initiation of clinical study to evaluate Caduet in treating high blood...

  • Swine Flu Vaccine: What Is Fair? Gostin, Lawrence O. // Hastings Center Report;Sep2009, Vol. 39 Issue 5, p9 

    No abstract available.

  • New products.  // Drug Topics;Oct2012, Vol. 156 Issue 10, p61 

    The article informs on various drugs and related products who have received approval from the Food & Drug Administration (FDA) in the U.S. It is mentioned that the FDA has approved the 2012-2013 influenza (flu) vaccine formulation of CSL Ltd., ID Biomedical Corp. and Sanofi Pasteur. Also,...

  • The Pulse on Technology. Tointon, Ashley // CenterWatch Weekly;2/3/2014, Vol. 18 Issue 5, p6 

    The article reports that the U.S. Food & Drug Administration (FDA) has released a new guidance entitled "Oversight of Clinical Investigations: A Risk-Based Approach to Monitoring." The guidance is aimed at monitoring clinical trials and ensuring protection of the patient as wll as integrity of...

  • Trial initiatives to protect patients, integrity of data. J. G. D. // Medical Marketing & Media;Aug2006, Vol. 41 Issue 8, p16 

    The article reports on the move of the U.S. Food and Drug Administration in releasing policy and regulatory initiatives intended to strengthen its oversight and protection of patients in clinical trials. The agency also aims to improve the integrity of clinical trial data used to make regulatory...

  • Underrepresentation of Older Adults in Cancer Trials. Luo, Jing; Kesselheim, Aaron S. // JAMA: Journal of the American Medical Association;3/5/2014, Vol. 311 Issue 9, p965 

    A letter to the editor is presented in response to the article by Dr. Hurria and colleagues on the view on the underrepresentation of older adults in cancer trials submitted for registration with the U.S. Food and Drug Administration (FDA) in issue 310(17): 1795-1796.

  • Underrepresentation of Older Adults in Cancer Trials. Cohen, Harvey Jay; Naylor, Mary; Hurria, Arti // JAMA: Journal of the American Medical Association;3/5/2014, Vol. 311 Issue 9, p966 

    A letter to the editor is presented in response to the article by Dr. Hurria and colleagues on the view on the underrepresentation of older adults in cancer trials submitted for registration with the U.S. Food and Drug Administration (FDA) in issue 310(17): 1795-1796.

  • Phase II data shows strong immunogenicity for ID Biomedical's FluINsure.  // PharmaWatch: Biotechnology;August 2003, Vol. 2 Issue 8, p7 

    Focuses on the clinical trials for FlulNsure, an intranasal, non-live, influenza vaccine developed by ID Biomedical Corp. Patients enrolled in the study; Presentation of the clinical study of FlulNsure; Evaluation on the efficacy of the influenza vaccine.

  • Need for Speed: FDA Pushes for Vaccine Approval Ahead of Data. Young, Donna // BioWorld Today;7/24/2009, Vol. 20 Issue 141, p3 

    This article reports on the plan of the U.S. Food and Drug Administration (FDA) in 2009 to approve a vaccine against the H1N1 swine-origin influenza A virus without waiting for data from required clinical trials in 2009. Advisers of the FDA supported the plan. The agency announced the plan in...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics